**Core Concept**
Acute humoral renal transplant rejection, also known as antibody-mediated rejection, is a type of rejection where the recipient's immune system produces antibodies against the transplanted kidney. This leads to activation of complement and coagulation pathways, ultimately causing damage to the graft.

**Why the Correct Answer is Right**
The correct answer is associated with the pathophysiology of acute humoral renal transplant rejection. This type of rejection is characterized by the presence of donor-specific antibodies, activation of the complement cascade, and deposition of immune complexes in the graft. The inflammatory response and subsequent tissue damage are mediated by the activation of complement proteins, such as C3 and C5, and the release of cytokines and chemokines.

**Why Each Wrong Option is Incorrect**
**Option A:** T-cell mediated rejection is a different type of rejection, characterized by the activation of T cells against the graft. It is not associated with the pathophysiology of acute humoral renal transplant rejection.
**Option B:** Hyperacute rejection is a type of rejection that occurs within minutes to hours after transplantation, due to pre-existing antibodies against the graft. While it is a type of antibody-mediated rejection, it is a distinct entity from acute humoral rejection.
**Option C:** Chronic rejection is a type of rejection that occurs over months to years after transplantation, characterized by fibrosis and vascular damage. It is not directly related to the pathophysiology of acute humoral renal transplant rejection.

**Clinical Pearl / High-Yield Fact**
Acute humoral renal transplant rejection can be difficult to diagnose, as the symptoms are often non-specific and may mimic other causes of graft dysfunction. A high index of suspicion and the use of immunohistochemical staining for complement proteins can help to establish the diagnosis.

**Correct Answer: D**